Prognostic Value of YKL-40 in Patients with Glioblastoma: a Systematic Review and Meta-analysis
出版年份 2016 全文链接
标题
Prognostic Value of YKL-40 in Patients with Glioblastoma: a Systematic Review and Meta-analysis
作者
关键词
Prognostic marker, Glioblastoma, YKL-40
出版物
MOLECULAR NEUROBIOLOGY
Volume 54, Issue 5, Pages 3264-3270
出版商
Springer Nature
发表日期
2016-04-18
DOI
10.1007/s12035-016-9878-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Biomarkers of glioblastoma multiforme
- (2015) Stylianos Nicolaidis METABOLISM-CLINICAL AND EXPERIMENTAL
- Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date
- (2014) Jayson I. L. Bastien et al. CANCER
- Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma
- (2014) Jaime Gállego Pérez-Larraya et al. CANCER
- The role of cytotoxic chemotherapy in the management of progressive glioblastoma
- (2014) Jeffrey J. Olson et al. JOURNAL OF NEURO-ONCOLOGY
- Emerging Therapies for Glioblastoma
- (2014) Alissa A. Thomas et al. JAMA Neurology
- Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
- (2014) Vladimir Riabov et al. Frontiers in Physiology
- Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle–Ottawa Scale and the RTI item bank
- (2014) Andrea V Margulis et al. Clinical Epidemiology
- The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy
- (2014) Mira Patel et al. Cancers
- Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
- (2014) Fabio M. Iwamoto et al. Frontiers in Oncology
- Diverse pathological implications of YKL-40: Answers may lie in ‘outside-in’ signaling
- (2013) Mansi Prakash et al. CELLULAR SIGNALLING
- Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients
- (2012) Maurizio Salvati et al. JOURNAL OF NEUROSURGERY
- Astrocyte and Macrophage Regulation of YKL-40 Expression and Cellular Response in Neuroinflammation
- (2011) Dafna Bonneh-Barkay et al. BRAIN PATHOLOGY
- Can YKL-40 be a new inflammatory biomarker in cardiovascular disease?
- (2011) Jens Kastrup IMMUNOBIOLOGY
- Serum YKL-40 following resection for cerebral glioblastoma
- (2011) Daniela Bernardi et al. JOURNAL OF NEURO-ONCOLOGY
- Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas
- (2011) F. M. Iwamoto et al. NEURO-ONCOLOGY
- CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells
- (2010) Bo Mi Ku et al. INTERNATIONAL JOURNAL OF CANCER
- In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases
- (2010) Dafna Bonneh-Barkay et al. Journal of Neuroinflammation
- Plasma YKL-40: a potential new cancer biomarker?
- (2009) Julia S Johansen et al. Future Oncology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started